ACCELERON PHARMA INC Insider Trading for September 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for September 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | VP, General Counsel ... | Sell | S | 45.75 | 23 | 1,052 | 16,101 | 16.1 K to 16.1 K (-0.14 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | VP, General Counsel ... | Sell | S | 45.18 | 801 | 36,189 | 16,124 | 16.9 K to 16.1 K (-4.73 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | VP, General Counsel ... | Sell | S | 45.75 | 23 | 1,052 | 16,101 | 16.1 K to 16.1 K (-0.14 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Sell | S | 45.24 | 3,389 | 153,318 | 86,986 | 90.4 K to 87 K (-3.75 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | VP, General Counsel ... | Sell | S | 45.18 | 801 | 36,189 | 16,124 | 16.9 K to 16.1 K (-4.73 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Quisel John D | EVP, Chief Business ... | Sell | S | 45.23 | 3,584 | 162,104 | 59,158 | 62.7 K to 59.2 K (-5.71 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Sell | S | 45.24 | 3,389 | 153,318 | 86,986 | 90.4 K to 87 K (-3.75 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 45.75 | 173 | 7,915 | 22,279 | 22.5 K to 22.3 K (-0.77 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Quisel John D | EVP, Chief Business ... | Sell | S | 45.23 | 3,584 | 162,104 | 59,158 | 62.7 K to 59.2 K (-5.71 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 45.29 | 7,827 | 354,485 | 22,452 | 30.3 K to 22.5 K (-25.85 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 45.75 | 173 | 7,915 | 22,279 | 22.5 K to 22.3 K (-0.77 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 45.29 | 7,827 | 354,485 | 22,452 | 30.3 K to 22.5 K (-25.85 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Dable Habib J | CEO and President | Sell | S | 45.67 | 344 | 15,710 | 70,883 | 71.2 K to 70.9 K (-0.48 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Dable Habib J | CEO and President | Sell | S | 45.20 | 5,281 | 238,701 | 71,227 | 76.5 K to 71.2 K (-6.90 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Dable Habib J | CEO and President | Sell | S | 45.67 | 344 | 15,710 | 70,883 | 71.2 K to 70.9 K (-0.48 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Dable Habib J | CEO and President | Sell | S | 45.20 | 5,281 | 238,701 | 71,227 | 76.5 K to 71.2 K (-6.90 %) |